James Eastham

James Eastham serves as Professor of Urology within the Surgery department at Memorial Sloan Kettering Cancer Center (MSKCC), specializing in prostate cancer surgical management and active surveillance protocols. His clinical role as Chief Attending underscores his leadership in urologic oncology.

His research focuses on prostate cancer biomarkers, surgical outcomes optimization, and advanced imaging techniques for recurrence detection. Key areas include PSA monitoring dynamics, MRI-guided biopsy decision-making, and post-prostatectomy rehabilitation. His work bridges clinical practice with translational research, emphasizing patient-centered outcomes in radical prostatectomy recovery and sexual health preservation.

Analysis of his 2025 publications reveals strong emphasis on prostate cancer screening refinement, minimally invasive surgical innovation, and evidence-based guideline development. His team frequently investigates biomarker validation (particularly PSA kinetics), imaging protocol enhancements for metastasis detection, and quality-of-life metrics following androgen deprivation therapy.

Eastham maintains extensive collaborative networks with prominent researchers including Scardino (256 co-publications), Vickers (127), and Touijer (84), reflecting his central role in MSKCC's urologic oncology ecosystem. His work appears predominantly in high-impact journals including Journal of Urology (80 publications), European Urology (55), and BJU International (45).

His clinical leadership drives protocol development for active surveillance programs and postoperative care pathways. Current projects focus on wearable rehabilitation technology (e.g., TechRing device), PSMA PET/CT optimization, and testosterone therapy safety in prostate cancer survivors.